These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36789289)

  • 1. Review of Literature on Intraductal Meibomian Gland Probing with Insights from the Inventor and Developer: Fundamental Concepts and Misconceptions.
    Warren NA; Maskin SL
    Clin Ophthalmol; 2023; 17():497-514. PubMed ID: 36789289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical results of Intraductal Meibomian gland probing combined with intense pulsed light in treating patients with refractory obstructive Meibomian gland dysfunction: a randomized controlled trial.
    Huang X; Qin Q; Wang L; Zheng J; Lin L; Jin X
    BMC Ophthalmol; 2019 Oct; 19(1):211. PubMed ID: 31660904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraductal meibomian gland probing and its efficacy in the treatment of meibomian gland dysfunction.
    Magno M; Moschowits E; Arita R; Vehof J; Utheim TP
    Surv Ophthalmol; 2021; 66(4):612-622. PubMed ID: 33352147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth of meibomian gland tissue after intraductal meibomian gland probing in patients with obstructive meibomian gland dysfunction.
    Maskin SL; Testa WR
    Br J Ophthalmol; 2018 Jan; 102(1):59-68. PubMed ID: 28592418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction.
    Cote S; Zhang AC; Ahmadzai V; Maleken A; Li C; Oppedisano J; Nair K; Busija L; Downie LE
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013559. PubMed ID: 32182637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling meibum secretion: Alternatives for obstructive Meibomian Gland Dysfunction (MGD).
    Luo S; Djotyan GP; Joshi R; Juhasz T; Brown DJ; Jester JV
    Ocul Surf; 2024 Jan; 31():56-62. PubMed ID: 38042297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, sham-controlled trial of intraductal meibomian gland probing with or without topical antibiotic/steroid for obstructive meibomian gland dysfunction.
    Kheirkhah A; Kobashi H; Girgis J; Jamali A; Ciolino JB; Hamrah P
    Ocul Surf; 2020 Oct; 18(4):852-856. PubMed ID: 32882429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal meibomian gland probing: background, patient selection, procedure, and perspectives.
    Maskin SL; Alluri S
    Clin Ophthalmol; 2019; 13():1203-1223. PubMed ID: 31371917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction.
    Maskin SL
    Cornea; 2010 Oct; 29(10):1145-52. PubMed ID: 20622668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Meibum Before and After Intraductal Meibomian Gland Probing in Eyes With Obstructive Meibomian Gland Dysfunction.
    Nakayama N; Kawashima M; Kaido M; Arita R; Tsubota K
    Cornea; 2015 Oct; 34(10):1206-8. PubMed ID: 26226474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Intraductal Meibomian Gland Probing on Tear Function in Patients With Obstructive Meibomian Gland Dysfunction.
    Ma X; Lu Y
    Cornea; 2016 Jun; 35(6):725-30. PubMed ID: 26967110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Intraductal Meibomian Gland Probing in Addition to the Conventional Treatment in Patients with Obstructive Meibomian Gland Dysfunction.
    Incekalan TK; Harbiyeli II; Yagmur M; Erdem E
    Ocul Immunol Inflamm; 2019; 27(8):1345-1351. PubMed ID: 30235042
    [No Abstract]   [Full Text] [Related]  

  • 13. Ductal Hyperkeratinization and Acinar Renewal Abnormality: New Concepts on Pathogenesis of Meibomian Gland Dysfunction.
    Du YL; Peng X; Liu Y; Wang JS; Ye YF; Xu KK; Qu JY; Chen H; Xie HT; Zhang MC
    Curr Issues Mol Biol; 2023 Feb; 45(3):1889-1901. PubMed ID: 36975492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meibomian Gland Probing Stimulates a Proliferative Epithelial Response Resulting in Duct Regeneration.
    Maskin SL; Toland C
    Clin Ophthalmol; 2024; 18():631-645. PubMed ID: 38445253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation Study Between Abnormal Morphology of Meibomian Glands and Meibum in Patients With Dry Eye Disease Under
    Zheng Q; Xue Y; Zhong X; Li G; Shi W; Wang T
    Front Med (Lausanne); 2021; 8():793338. PubMed ID: 35096880
    [No Abstract]   [Full Text] [Related]  

  • 16. Categorization of Meibomian Gland Dysfunction Using Lipid Layer Thickness and Meibomian Gland Dropout in Dry Eye Patients: A Retrospective Study.
    Lee PK; Chung JL; Kim DR; Yoon YC; Yang S; Whang WJ; Byun YS; Hwang H; Na KS; Lee H; Chung SH; Kim EC; Cho Y; Kim HS; Hwang HS
    Korean J Ophthalmol; 2024 Feb; 38(1):64-70. PubMed ID: 38148689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging treatment options for meibomian gland dysfunction.
    Qiao J; Yan X
    Clin Ophthalmol; 2013; 7():1797-803. PubMed ID: 24043929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Meibomian Gland Openings by Optical Coherence Tomography in Obstructive Meibomian Gland Dysfunction and Normal Patients.
    Cui X; Wu Q; Zhai Z; Yang Y; Wei A; Xu J; Hong J
    J Clin Med; 2020 Sep; 9(10):. PubMed ID: 33008054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful reversal of neuropathic eye pain by treatment of occult ocular surface disease: Case series and implications.
    Maskin SL
    Am J Ophthalmol Case Rep; 2022 Sep; 27():101662. PubMed ID: 35873369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LipiFlow for the treatment of dry eye disease.
    Pucker AD; Yim TW; Rueff E; Ngo W; Tichenor AA; Conto JE
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD015448. PubMed ID: 38314898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.